Scientific Collaboration in the Development of New Drugs: The Path to Progress and Innovation in the Pharmaceutical Industry
with Jack Henion, PhDCo-Founder, Chief Scientific Officer and Chairman
Building on the success of our Business of Science events over the past year, we are delighted to introduce a new seminar series designed to help postdocs and other UT scholars bridge the gap between academia and industry.
Co-hosted by Pain Therapeutics, Inc, this event features Dr Jack Henion, an internationally recognized leader in the field of mass spectrometry. He is credited with nine patents and has published more than 200 peer-reviewed papers in scientific journals. In addition to his work at Advion in Ithaca, NY, Dr Henion managed a major research laboratory at Cornell University, where he served as Professor of Toxicology for more than 24 years and is now Emeritus Professor of Analytical Toxicology. Under his leadership and vision, Advion has established itself as one of the largest and most respected LC/MS contract laboratories in the world and a leader in chip-based nanoelectrospray mass spectrometry.
Many thanks to Advion for sponsoring the reception immediately following Dr Henion’s talk in the NHB 3rd-floor lounge.
Please download the event flier and post in your office or lab.Dr Henion earned a bachelor’s degree from Alfred University, a master’s of science from the Rochester Institute of Technology, a PhD from the State University of New York in Albany and a postdoctoral appointment at the University of North Carolina, Chapel Hill. The American Association of Pharmaceutical Scientists has recognized him as a Fellow for his contributions to analytical chemistry. In recognition of his contributions in the field of MS, Dr. Henion has received honorary doctorate degrees from the University of Ghent, Belgium and the University of Uppsala, Sweden. Dr Henion is also a member of the American Chemical Society, the American Society for Mass Spectrometry, and the Royal Society of Chemistry (BA FRSC).